These findings revealed that hypoxia-induced NF-κB/p65 competed with PPARγ for TRPC6 binding, resulting in increased TRPC1/6 activity, elevated SOCE and Ca2+ influx, increased hPASMC proliferation, and developed PAH. The gene discussed is NFKB1; the disease is pulmonary arterial hypertension.